We are live on ! Find out more
HURA

TuHURA Biosciences

50 hedge funds and large institutions have $14.2M invested in TuHURA Biosciences in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 1

600% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 4

85% more funds holding

Funds holding: 2750 (+23)

21% more capital invested

Capital invested by funds: $11.8M → $14.2M (+$2.44M)

5.98% more ownership

Funds ownership: 8.64%14.63% (+6%)

Holders
50
Holders Change
+23
Holders Change %
+85.19%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
13
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JFG
51
Jefferies Financial Group
New York
-$42.6K -13,200 Closed
Squarepoint
52
Squarepoint
New York
-$40.4K -12,506 Closed
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
+$405 +120 New

HURA Hedge Fund Activity: Q2 2025 in Review

50 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2025, worth a combined $14.2M — up 21% from $11.8M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new HURA positions and 4 closed out — a net gain of 24 holders — while 13 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, adding an estimated $3.26M. The largest seller was Jane Street, exiting entirely with an estimated $69.1K sold.

  • 50 institutional investors held TuHURA Biosciences (HURA) as of Q2 2025, up from 27 in Q1 2025.
  • Funds reported $14.2M of TuHURA Biosciences stock for Q2 2025, up 21% quarter-over-quarter.
  • 28 funds opened new TuHURA Biosciences positions in Q2 2025 and 4 closed out, a net change of +24 holders.
  • The largest TuHURA Biosciences buyer in Q2 2025 was BlackRock, an estimated $3.26M added.
  • The largest TuHURA Biosciences seller in Q2 2025 was Jane Street, an estimated $69.1K sold.

Based on aggregated 13F filings for Q2 2025.